107 related articles for article (PubMed ID: 11107182)
21. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
[TBL] [Abstract][Full Text] [Related]
23. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
24. Lack of BCL10 mutations in multiple myeloma and plasma cell leukemia.
Shih LY; Fu JF; Shurtleff SA; Morris SW; Downing JR
Genes Chromosomes Cancer; 2001 Apr; 30(4):402-6. PubMed ID: 11241793
[TBL] [Abstract][Full Text] [Related]
25. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
[TBL] [Abstract][Full Text] [Related]
26. Aggressive mucosa associated lymphoid tissue lymphomas are associated with mutations in Bcl10.
Spencer J
Gut; 1999 Jun; 44(6):778-9. PubMed ID: 10323877
[No Abstract] [Full Text] [Related]
27. No evidence for BCL10 mutation in endometrial cancers with microsatellite instability.
Cohn D; Mutch D; Elbendary A; Rader J; Herzog T; Goodfellow P
Hum Mutat; 2001 Feb; 17(2):117-21. PubMed ID: 11180594
[TBL] [Abstract][Full Text] [Related]
28. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas.
Fakruddin JM; Chaganti RS; Murty VV
Cell; 1999 Jun; 97(6):683-4; discussion 686-8. PubMed ID: 10380920
[No Abstract] [Full Text] [Related]
29. Transcriptome sequencing of malignant pleural mesothelioma tumors.
Sugarbaker DJ; Richards WG; Gordon GJ; Dong L; De Rienzo A; Maulik G; Glickman JN; Chirieac LR; Hartman ML; Taillon BE; Du L; Bouffard P; Kingsmore SF; Miller NA; Farmer AD; Jensen RV; Gullans SR; Bueno R
Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3521-6. PubMed ID: 18303113
[TBL] [Abstract][Full Text] [Related]
30. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network.
Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW
J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408
[TBL] [Abstract][Full Text] [Related]
31. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines.
van Schothorst EM; Mohkamsing S; van Gurp RJ; Oosterhuis JW; van der Saag PT; Looijenga LH
Br J Cancer; 1999 Jul; 80(10):1571-4. PubMed ID: 10408400
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
Tadokoro J; Nakamura Y; Furusawa S; Mitani K
Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
[TBL] [Abstract][Full Text] [Related]
33. Lack of Bcl10 mutations in malignant cartilaginous tumors.
Park YK; Park HR; Kim YW; Chi SG; Unni KK
Int J Mol Med; 2002 Mar; 9(3):217-9. PubMed ID: 11836626
[TBL] [Abstract][Full Text] [Related]
34. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types.
Willis TG; Jadayel DM; Du MQ; Peng H; Perry AR; Abdul-Rauf M; Price H; Karran L; Majekodunmi O; Wlodarska I; Pan L; Crook T; Hamoudi R; Isaacson PG; Dyer MJ
Cell; 1999 Jan; 96(1):35-45. PubMed ID: 9989495
[TBL] [Abstract][Full Text] [Related]
35. Mutation study of the BCL10 gene in lymphoma with both RNA and DNA.
Tsushita K; Ohashi H; Utsumi M; Shimoyama M; Nagai H; Kinoshita T
Leukemia; 2001 Jul; 15(7):1139-40. PubMed ID: 11455987
[No Abstract] [Full Text] [Related]
36. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLH1.
Wheeler JM; Beck NE; Kim HC; Tomlinson IP; Mortensen NJ; Bodmer WF
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10296-301. PubMed ID: 10468602
[TBL] [Abstract][Full Text] [Related]
37. Lack of mutations of BCL6 and BCL10 genes in mucosa-associated lymphoid tissue lymphomas of the orbital adnexa.
Chen PM; Liu JH; Yu IT; Kao SC; Lin YC; Chiang H; Fan FS; Chiou TJ; Wang WS; Yen CC
Cancer Genet Cytogenet; 2000 Nov; 123(1):44-8. PubMed ID: 11120333
[TBL] [Abstract][Full Text] [Related]
38. Mutational analysis of the nf2 tumour suppressor gene in three subtypes of primary human malignant mesotheliomas.
Schipper H; Papp T; Johnen G; Pemsel H; Bastrop R; Müller KM; Wiethege T; Jaworska M; Krismann M; Schiffmann D; Rahman Q
Int J Oncol; 2003 May; 22(5):1009-17. PubMed ID: 12684666
[TBL] [Abstract][Full Text] [Related]
39. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
Yuille MR; Stone JG; Bradshaw PS; Houlston RS
Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
[TBL] [Abstract][Full Text] [Related]
40. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
Bianchi AB; Mitsunaga SI; Cheng JQ; Klein WM; Jhanwar SC; Seizinger B; Kley N; Klein-Szanto AJ; Testa JR
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10854-8. PubMed ID: 7479897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
